[시장보고서]구조 흡입기 시장 : 제품 유형별, 적응증별, 환자 유형별, 투약형별, 최종 사용자별, 지역별

구조 흡입기 시장 : 제품 유형별, 적응증별, 환자 유형별, 투약형별, 최종 사용자별, 지역별

Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography

상품코드 : 1741411

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,501,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,113,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,448,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

구조 흡입기 시장은 2025년에는 199억 5,000만 달러로 추정되고, 2032년에는 360억 달러에 이를 전망이며, 2025-2032년 CAGR 8.8%로 성장이 예측되고 있습니다.

보고 범위		보고서 세부정보
기준 연도	2024년	시장 규모(2025년)	199억 5,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년) :	8.80%	예측 금액(2032년)	360억 달러

구조 흡입기는 릴리버 흡입기로도 알려져 있으며 천식과 만성 폐색성 폐질환(COPD) 등의 호흡기 질환을 가진 사람이 일반적으로 사용하는 약물 장치입니다. 천식 발작 및 호흡 곤란 시 기도를 넓히는 즉효성 기관지 확장약이 포함되어 있습니다. 이 약은 천명, 숨이 차거나 가슴이 답답해지는 등의 증상을 빠르게 완화합니다. 구조 흡입기는 신속한 완화를 초래하지만 증상의 근본적인 원인을 치료하는 것은 아닙니다. 급성 호흡기 증상을 관리하고 환자의 삶의 질을 향상시키기 위해 필수적인 도구입니다.

시장 역학 :

호흡기 질환의 유병률 증가, 노년 인구 증가, 의료 지출 증가는 예측 기간에 걸쳐 세계 구조 흡입기 시장의 성장을 가속할 것으로 예측됩니다. 또한 기술의 진보도 예측 기간 동안 세계 구조 흡입기 시장의 성장을 뒷받침할 것으로 예상됩니다. 신흥국 시장에서의 높은 성장 잠재력, 재가 케어 환경 수요 확대, 천식용 생물제제 개발, 호흡기 케어를 위한 원격 의료에 대한 관심 고조는 예측 기간 동안 세계의 구조 흡입기 시장에 성장 기회를 가져올 것으로 예상됩니다.

그러나 엄격한 규제 요건, 흡입기 부작용 및 흡입기의 높은 비용은 예측 기간 동안 구조 흡입기 시장의 성장을 방해할 것으로 예측됩니다.

이 조사의 주요 특징

본 보고서는 구조 흡입기 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 구조 흡입기 시장의 주요 기업 프로파일을 제공합니다.
이 보고서의 인사이트를 통해 마케팅 담당자 및 기업 경영진이 미래의 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 할 수 있게 합니다.
구조 흡입기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 지원합니다.
이해관계자는 구조 흡입기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

시장 역학
- 성장 촉진요인
호흡기 질환 유병률 상승
고령화 인구 증가
제품 승인 향상
- 성장 억제요인
엄격한 규제 요건
제품 리콜
흡입기의 고비용
- 기회
호흡기 케어에 있어서 원격 의료에 대한 주목 고조
천식에 대한 생물학적 제제 개발
신흥 시장에서 높은 성장 가능성
영향 분석
주요 하이라이트
규제 시나리오
제품 출시 및 승인
PEST 분석
Porter's Five Forces 분석
합병 및 인수 시나리오

제4장 구조 흡입기 시장 : 코로나 바이러스(COVID-19) 유행의 영향

COVID-19 역학
공급측 및 수요측 분석
경제에 미치는 영향

제5장 구조 흡입기 시장 : 제품 유형별(2020-2032년)

정량 분무식 흡입기
드라이 파우더 흡입기
분무기
소프트 미스트 흡입기
기타

제6장 구조 흡입기 시장 : 적응증별(2020-2032년)

천식
COPD
알레르기성 비염
폐동맥고혈압
기타

제7장 구조 흡입기 시장 : 환자 유형별(2020-2032년)

성인
소아

제8장 구조 흡입기 시장 : 제형별(2020-2032년)

캡슐
액체
서스펜션
기타

제9장 구조 흡입기 시장 : 최종 사용자별(2020-2032년)

재택치료
병원 및 진료소

제10장 구조 흡입기 시장 : 지역별(2020-2032년)

북미
유럽
아시아태평양
라틴아메리카
중동
아프리카

제11장 경쟁 구도

GSK plc.
Teva Pharmaceutical Industries Ltd.
Cipla Inc.
PARI Pharma GmbH
Lupin
AstraZeneca
Boehringer Ingelheim International GmbH.
Novartis
Pfizer
Sunovion Pharmaceuticals
3M
OMRON Healthcare Co., Ltd.
Koninklijke Philips NV
Invacare
Schiller
Teleflex Incorporated

제12장 섹션

조사 방법
출판사에 대해

AJY

영문 목차

영문목차

Rescue Inhaler Market is estimated to be valued at USD 19.95 Bn in 2025 and is expected to reach USD 36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 19.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 36 Bn

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Rescue Inhaler Market Detailed Segmentation:

By Product Type:
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Soft Mist Inhalers
- Others
By Indication:
- Asthma
- COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Others
By Patient Type:
- Adult
- Pediatric
By Dosage Form:
- Capsules
- Solution
- Suspension
- Others
By End User:
- Home Care Settings
- Hospitals & Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- Omron Healthcare
- Koninklijke Philips N.V.
- Invacare
- Schiller
- Teleflex Incorporated

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By Patient Type
- Market Snippet, By Dosage Form
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of respiratory diseases
Increasing geriatric population
Increasing Product Approval
- Restraints
Stringent regulatory requirements
Product Recall
High cost of inhalers
- Opportunities
Rising focus on telehealth for respiratory care
Development of biologics for asthma
High growth potential in emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Rescue Inhaler Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Metered Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Dry Powder Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - North Africa
  - South Africa
  - Central Africa

11. Competitive Landscape

GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PARI Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
OMRON Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invacare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Schiller
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us